Page 3 - Juul Lab News Today

Recent health news includes drugmaker WuXi AppTec working with Chinese military scientists on altitude sickness treatments, FDA halting Biomea's diabetes trials due to liver toxicity, and a bird flu outbreak in Minnesota. Additionally, an antitrust probe into pharmaceutical companies over an eye drug and Novo Nordisk facing generic challenges in China are reported.

Health-care companies rose as traders rotated into the defensive sector, unsure what the future holds for interest rates. Gene-technology firm Illumina surged, logging one of its largest gains... -June 06, 2024 at 05:33 pm EDT - MarketScreener

The Food and Drug Administration rescinded the marketing denial orders it had issued to Juul Labs in 2022.

MARKET WRAPS Watch For: S&P manufacturing PMI; Construction Spending for December Todays Top Headlines/Must Reads: - New Disruptions, Geopolitics Hang Over 2024 Supply Chains -... -January 02, 2024 at 06:13 am EST - MarketScreener

Two of Juul Labs’ longtime directors—a Hyatt Hotels heir and a venture capitalist—helped bail out the e-cigarette maker when it was on the brink of…

Lawsuit accuses two directors of benefiting themselves through corporate financial maneuvers; Juul says decisions were made in company’s best interests

The latest TV and book reviews from the expert team here at MoneyWeek.

The FDA has reportedly ordered Reynolds American to stop selling menthol-flavored versions of its Vuse Alto e-cigarette.

Juul Labs is hoping the U.S. Food and Drug Administration will approve a new product for the e-cigarette company.

Juul Labs is hoping the U.S. Food and Drug Administration will approve a new product for the e-cigarette company.